GreenLight Biosciences Holdings, PBC (GRNA) enters into multitarget licensing agreement with Serum Institute of India to develop and commercialize messenger RNA products for emerging markets globally
GlobeNewswire
· Serum Institute of India has engaged GreenLight to design three messenger RNA products, including a vaccine for shingles. Serum..
